MA48455B1 - Composés antitumoraux - Google Patents

Composés antitumoraux

Info

Publication number
MA48455B1
MA48455B1 MA48455A MA48455A MA48455B1 MA 48455 B1 MA48455 B1 MA 48455B1 MA 48455 A MA48455 A MA 48455A MA 48455 A MA48455 A MA 48455A MA 48455 B1 MA48455 B1 MA 48455B1
Authority
MA
Morocco
Prior art keywords
antitumor compounds
antitumor
compounds
cancer
compound
Prior art date
Application number
MA48455A
Other languages
English (en)
Other versions
MA48455A (fr
Inventor
Marchante Maria Del Carmen Cuevas
Solloso Andres Francesch
Barrasa Valentin Martinez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Priority claimed from PCT/EP2018/060868 external-priority patent/WO2018197663A1/fr
Publication of MA48455A publication Critical patent/MA48455A/fr
Publication of MA48455B1 publication Critical patent/MA48455B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne un composé de formule générale i, dans laquelle r1 à r4 ont diverses significations, et est destiné à être utilisé dans le traitement du cancer.
MA48455A 2017-04-27 2018-04-27 Composés antitumoraux MA48455B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382228 2017-04-27
PCT/EP2018/060868 WO2018197663A1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Publications (2)

Publication Number Publication Date
MA48455A MA48455A (fr) 2020-03-04
MA48455B1 true MA48455B1 (fr) 2023-06-28

Family

ID=58668823

Family Applications (3)

Application Number Title Priority Date Filing Date
MA48455A MA48455B1 (fr) 2017-04-27 2018-04-27 Composés antitumoraux
MA57420A MA57420B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux
MA58643A MA58643B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Family Applications After (2)

Application Number Title Priority Date Filing Date
MA57420A MA57420B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux
MA58643A MA58643B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Country Status (2)

Country Link
AR (1) AR114387A1 (fr)
MA (3) MA48455B1 (fr)

Also Published As

Publication number Publication date
AR114387A1 (es) 2020-09-02
MA48455A (fr) 2020-03-04
MA58643B1 (fr) 2023-09-27
MA57420B1 (fr) 2023-06-28

Similar Documents

Publication Publication Date Title
MA44021B1 (fr) Composés antitumoraux
MA52486B1 (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
MA52948B1 (fr) Composés
MA34361B1 (fr) Dérivés de tétrahydro-pyrido-pyrimidine
MA39189A1 (fr) Dérivés de 1h-indazole et de 1h-indole antibactériens
MA41562B1 (fr) Agonistes d'apj 4-hydroxy-3-(heteroaryl)pyridine-2-one a utiliser dans le traitement de troubles cardio-vasculaires
MA42109B1 (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
EA201690153A1 (ru) Замещенные бензофуранильные и бензоксазолильные соединения и их применения
MA37866B1 (fr) Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur
EP3520785A4 (fr) Utilisation d'une formule renfermant un agent bactériostatique pour la préparation d'un composé à application vaginale et ledit composé
MA38645A1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA35342B1 (fr) Composés de-pipéridinyle utiles comme inhibiteurs de la tankyrase
MA40221A (fr) Dérivés d'isoindoline à utiliser dans le traitement d'une infection virale
FR3066761B1 (fr) Nouveaux composes inhibiteurs des canaux ioniques
MA39305A3 (fr) Dérivés d'éthynyle
MA46039B1 (fr) Dérivé de triazolopyrazinone utile en tant qu'inhibiteur de pde1 humain
EA201891240A1 (ru) 1,3,4-тиадиазольные соединения и их применение в лечении рака
MA38857A1 (fr) Dérivés de 1-(pipérazin-1-yl)-2-([1,2,4]triazol-1-yl)-éthanone
FR3020809B1 (fr) Derives de 4-vinyl-2cyclopentene-1-one leur preparation et leur utilisation en tant qu'agent antibiotique
MA20150280A2 (fr) Dérivés d'aryléthynyle
MA48455B1 (fr) Composés antitumoraux
MA41885B1 (fr) Mélange d'additifs
FR3047665B1 (fr) Celastrol et ses derives dans le traitement des tumeurs et pathologies pre-cancereuses cutanees
MA39529B1 (fr) Agent stabilisant hautement efficace
EA201891987A1 (ru) Производное 5-метил-6-фенил-4,5-дигидро-2h-пиридазин-3-она